Wickes Group PLC Transaction in Own Shares

RNS Number : 6572D

Wickes Group PLC

11 September 2024

 

11^th September 2024

Wickes Group plc

("Wickes" or the "Company")

Transaction in Own Shares

 

Wickes Group plc ("Wickes" or the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each through Peel Hunt LLP ("Peel Hunt").

Ordinary Shares

Date of purchase:	10 September 2024
Number of ordinary shares purchased:	58,827
Lowest price per share (pence):	164.0000
Highest price per share (pence):	173.8000
Weighted average price per day (pence):	170.1915

 

The Company intends to cancel the purchased shares.

 

Including the above purchases, Wickes has purchased a total of 17,411,101 ordinary shares since the commencement of the buyback programme. 

Following the purchase and cancellation of these shares, the Company's issued share capital will consist of 242,226,897. The Company does not hold any shares in Treasury.

 

Once the shares are cancelled, the total number of voting rights in Wickes will therefore be 242,226,897. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. 

 

The table below contains detailed information about the purchases made as part of the buyback programme.

  

Aggregate information:

Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
XLON	170.1915	58,827	164.0000	173.8000

 

 

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company as part of the Programme is detailed below

Date and time of each trade	Number of shares purchased	Price (pence per share)	Trading Venue	Transaction Reference Number
10 September 2024 08:00:19	1762	164	XLON	00166324392TRLO0
10 September 2024 08:12:47	1289	167.8	XLON	00166326391TRLO0
10 September 2024 08:12:47	366	167.8	XLON	00166326392TRLO0
10 September 2024 08:19:23	1693	171	XLON	00166326933TRLO0
10 September 2024 08:23:02	1014	170.6	XLON	00166327216TRLO0
10 September 2024 08:23:02	641	170.6	XLON	00166327217TRLO0
10 September 2024 08:24:56	1679	171.8	XLON	00166327359TRLO0
10 September 2024 08:37:38	1477	173.8	XLON	00166328416TRLO0
10 September 2024 08:40:59	1559	173.2	XLON	00166329014TRLO0
10 September 2024 08:46:35	1608	171.6	XLON	00166329495TRLO0
10 September 2024 08:46:36	472	171.4	XLON	00166329498TRLO0
10 September 2024 08:46:49	1197	171.4	XLON	00166329503TRLO0
10 September 2024 08:47:12	1565	170.6	XLON	00166329532TRLO0
10 September 2024 08:51:01	1737	170.8	XLON	00166329909TRLO0
10 September 2024 08:53:19	1708	171	XLON	00166330161TRLO0
10 September 2024 09:03:23	1648	171.2	XLON	00166330842TRLO0
10 September 2024 09:13:24	350	170.2	XLON	00166331576TRLO0
10 September 2024 09:13:24	1135	170.2	XLON	00166331577TRLO0
10 September 2024 09:18:41	25927	169.998	XLON	00166331921TRLO0
10 September 2024 16:18:02	10000	169.8	XLON	00166367764TRLO0

 

For further information please contact:

 

 

Holly Grainger

Director of Investor Relations

07341 680426

[e-mail]

 

Lucy Legh, Will Smith
Headland - PR Adviser to the Company
[phone]
[e-mail]

 

LEI: 213800IEX9ZXJRAOL133

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSURVBRSWUKAAR